DHR — Danaher Corporation
$230.50+0.33%
Last close: · regular session
Last 60 sessions
DHR closed at $230.50 (+0.33%) on Oct 23, 2026. Float: 626.4M shares. Latest SEC filing: 8-K on Jul 21, 2026.
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for DHR in the TickerWise workspace.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Company profile
- Sector: Healthcare
- Industry: Medical - Diagnostics & Research
- Country: US
- Exchange: NYSE
- Employees: 61,000
- Website: https://www.danaher.com
Latest SEC filings for DHR
Latest DHR news
- LH vs. DHR: Which Stock Is the Better Value Option? Read article
- DHR Q3 Earnings Beat on Biotechnology Strength, Sales in Line Read article
- Danaher drops after Q3 revenue miss amid CEO transition Read article
- Danaher (DHR) Tops Q3 Earnings and Revenue Estimates Read article
- Danaher Non-GAAP EPS of $2.11 beats by $0.19, revenue of $6.55B misses by $10M Read article
- Will Danaher (DHR) Beat Estimates Again in Its Next Earnings Report? Read article
- Danaher (DHR) Earnings Expected to Grow: Should You Buy? Read article
- Danaher Collaborates with NVIDIA to Advance Autonomous Science Read article
Related companies
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.